These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23209745)

  • 21. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.
    Sunagar R; Kumar S; Franz BJ; Gosselin EJ
    Vaccine; 2016 Jun; 34(29):3396-404. PubMed ID: 27182819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
    Cong Y; Yu JJ; Guentzel MN; Berton MT; Seshu J; Klose KE; Arulanandam BP
    Vaccine; 2009 Sep; 27(41):5554-61. PubMed ID: 19651173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Synthetic Tul4 and FopA Peptide Cocktail of Francisella tularensis Induces Humoral and Cell-Mediated Immune Responses in Mice.
    Oh H; Kim CY; Kim CH; Hur GH; Park JH
    J Microbiol Biotechnol; 2016 Sep; 26(9):1613-9. PubMed ID: 27238938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium.
    Sjöstedt A; Sandström G; Tärnvik A
    Infect Immun; 1992 Jul; 60(7):2855-62. PubMed ID: 1612751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis.
    Kirimanjeswara GS; Golden JM; Bakshi CS; Metzger DW
    J Immunol; 2007 Jul; 179(1):532-9. PubMed ID: 17579074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
    Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
    J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
    Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
    Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains.
    Mara-Koosham G; Hutt JA; Lyons CR; Wu TH
    Infect Immun; 2011 Apr; 79(4):1770-8. PubMed ID: 21282410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis.
    Golovliov I; Ericsson M; Akerblom L; Sandström G; Tärnvik A; Sjöstedt A
    Vaccine; 1995 Feb; 13(3):261-7. PubMed ID: 7631511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.
    Roberts LM; Davies JS; Sempowski GD; Frelinger JA
    Vaccine; 2014 Jun; 32(29):3595-603. PubMed ID: 24837506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection.
    Metzger DW; Salmon SL; Kirimanjeswara G
    Infect Immun; 2013 Jun; 81(6):2022-7. PubMed ID: 23529615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis.
    Jia Q; Lee BY; Clemens DL; Bowen RA; Horwitz MA
    Vaccine; 2009 Feb; 27(8):1216-29. PubMed ID: 19126421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis.
    Rawool DB; Bitsaktsis C; Li Y; Gosselin DR; Lin Y; Kurkure NV; Metzger DW; Gosselin EJ
    J Immunol; 2008 Apr; 180(8):5548-57. PubMed ID: 18390739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
    Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.
    Huntley JF; Conley PG; Rasko DA; Hagman KE; Apicella MA; Norgard MV
    Infect Immun; 2008 Aug; 76(8):3664-71. PubMed ID: 18505805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection.
    Furuya Y; Kirimanjeswara GS; Roberts S; Metzger DW
    Infect Immun; 2013 Sep; 81(9):3434-41. PubMed ID: 23836815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.
    Dreisbach VC; Cowley S; Elkins KL
    Infect Immun; 2000 Apr; 68(4):1988-96. PubMed ID: 10722593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    De Pascalis R; Hahn A; Brook HM; Ryden P; Donart N; Mittereder L; Frey B; Wu TH; Elkins KL
    PLoS One; 2018; 13(5):e0198140. PubMed ID: 29799870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.